A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 84
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DYS
Long Form : dysplasia
No. Year Title Co-occurring Abbreviation
2017 A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer. CAG, CSG, GC, HDAC6, HP, IM
2017 Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. 5-ASA, CD, CIs, CRC, IBD, ORs, UC
2017 Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis. CAG, CSG, GC, IM, MZF1, qRT-PCR
2017 Quantitative changes of gastric mucosa during carcinogenesis using stereological methods. GC, H. pylori, IHC, IM, PMN
2017 [Relationship between Helicobacter pylori infection and miR-24-3p expression during the development of gastric mucosa lesions]. CAG, CSG, H. pylori, IM, miR-24-3p
2016 Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population. CAG, CI, ELISA, GC, H. pylori, IL, IM, OR, SNPs
2016 Hypomethylation of repetitive elements in blood leukocyte DNA and risk of gastric lesions in a Chinese population. CI, GC, IM, ORs
2016 Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study. BE, CE, DE, EMR, IMC, RFA
2015 Clinical characteristics of lichen and dysplasia vs lichen planus cases and dysplasia cases. LD, LP/LR
10  2015 Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. CAG, GCA, NOR, TAAs
11  2015 GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis. CAG, Cx43, GATA3, GC, H. pylori, IM, NAG, NGM
12  2015 Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population. CAG, CIs, GC, IM, ORs, qMSP, SG
13  2014 Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. BCH, ESCC, NOR, TAAs
14  2014 Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis. BSP, CAG, Cx, GC, H. pylori, IM, MSP, NAG, NGM, PCR
15  2014 Expression of gammaH2AX in various gastric pathologies and its association with Helicobacter pylori infection. CG, DSBs, GC, H. pylori, IM
16  2014 Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. ORs
17  2014 Methylation status of blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population. CI, IM, SG/CAG
18  2014 Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China. ESCC, HPV
19  2013 [Effects of xinwei granule on STAT3 and p-STAT3 signal pathway in rats with precancerous lesion of gastric cancer]. IM, MNNG, PLGC, pSTAT3, STATs, XG
20  2012 Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion. BCH, ESCC, HC, PCLs, SELDI-TOF-MS, SVM
21  2012 Correlation of epigenetic aberrance with STAT3 signaling pathway in gastric carcinogenesis. AGC, EGC, IM
22  2012 Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. CG, GC, IM, NGM
23  2012 Value of c-Met for Predicting Progression of Precancerous Gastric Lesions in Rural Chinese Population. IM, OR
24  2011 Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry. CAG, CSG, GC, IM, PCA
25  2011 RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. CI, IM, Ind DYS, ORs
26  2011 The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer. CAG, CSG, GC, IM
27  2011 The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. AG, GSRS, IM
28  2011 [Clinical and pathological study of weiyan serial recipes in the treatment of gastric precancerous lesions]. CAG, HIF-1alpha, IM, VEGF, WYSR
29  2010 Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. AG, IM
30  2010 Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia. AOD, CAG, COX-2, CSG, IM, VEGF
31  2010 Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients. CIS, HAL
32  2010 Expression of polycomb protein EZH2 in multi-stage tissues of gastric carcinogenesis. CAG, EZH2, GC, IM, NCAG, PcG
33  2010 Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions. CAG, CR-1, GC, IM, pSTAT3
34  2009 [Identification of biomarkers for early detection in gastric cancer and its clinical biological significance.]. CR, DEGs, GC, IHC, IM, NAT
35  2009 [Relationship between RUNX3 expression and precancerous gastric lesions in high-risk population]. CI, H. pylori, OR, SG/N
36  2008 High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. CAs, CISH, HR-HPV, PAs, PCR, VCNs
37  2007 Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. AG, IM
38  2006 Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. CIS, ESCC
39  2006 [Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof]. CAG, COX-2, CSG, HP, MI, PPARgamma
40  2006 [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China]. BCH, EC, SELDI-TOF-MS
41  2005 Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions. APC, IDys, IGC, PCNA, RH
42  2005 Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach. CAG, GC, IM, pol beta
43  2005 Neural network classification of laser-induced 5-ALA-PpIX fluorescence spectra using adaptive principal component extraction. AC, APEX, BW, EC, RBPNN
44  2005 Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. BCH, ESCC
45  2005 Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. HGD, IGC, IM, LGD
46  2005 [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study]. CAG, GC, H. pylori, IM, SG
47  2005 [The application of surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in diagnosing dysplasia and chronic atrophic gastric-carditis in population with high risk of gastric-cardia adenocarcinoma]. CAG, GCA, SELDI-TOF-MS
48  2004 Expression of COX-2 proteins in gastric mucosal lesions. IM
49  2004 Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection. cag A, GC, H. pylori, IM, NF-kappaB
50  2004 Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. ---
51  2004 Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas. BCH, ESCC, GRP, RT-PCR
52  2004 p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. CAG, GC, IM
53  2004 [Centrosome hyperamplificationin oral precancerous lesions and squamous cell carcinomas]. ---
54  2004 [Expression of NFkappaB p65 and its target genes in gastric cancer and precancerous lesions]. GC, HP, IM
55  2003 Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. BCH, CIS, GCA, NOR, SCC
56  2003 Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis. CAG, CNAG, IM, NM
57  2003 Expression of 1A6 gene and its correlation with intestinal gastric carcinoma. IGC, IM, SAG, SG
58  2003 [The relation between Helicobacter pylori infection and p53 mutation, MG-7 antigen and AgNORs expression in the development of gastric mucosa lesions]. AgNORs, GC, IM
59  2002 Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. BCH, CIS, E-cad, ESCC, HLA, VHL
60  2002 Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China. BCH, EC, HIA, LIA, PCNA, SCC
61  2002 Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. CAG, CSG, IM, iNOS, VEGF
62  2001 Aberrant Crypt Foci in the Background Mucosa of Colorectal Adenocarcinoma. AD, HP, SH
63  2001 Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation. NOM, SCC, VEGF
64  2001 [The prognostic research of expression and relationship between Helicobacter pylori of c-met oncogene correlation with gastric mucosal proliferation]. CSG, GC, HP, PCNA
65  2000 Blood type and family cancer history in relation to precancerous gastric lesions. CAG, IM, OR, SG
66  2000 Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging. CAG, GC, H. pylori, IM
67  1999 Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: study of a high-risk population in northern China. BCH, PCNA, SCC
68  1999 Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. CAG, GC, IM, ORs, SG
69  1999 Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. BCH, CIS, IHSS, SCC
70  1998 Clinical and experimental study of therapeutic effect of Weixibaonizhuan pills on gastric precancerous lesions. IM
71  1998 Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. CAG, CI, GC, IM, OR, SG
72  1998 Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization. ALDH2, BCH, CIS
73  1998 Precancerous lesions in two counties of China with contrasting gastric cancer risk. GC, IM
74  1998 [Relationship between the mRNA transcriptions of bFGF and KGF in the carcinogenesis of oral mucosa]. SCC
75  1998 [Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]. CAG, GC, IM, NT, TRAP
76  1997 An evaluation of the role of nuclear cytoplasmic ratios and nuclear volume densities as diagnostic indicators in metaplastic, dysplastic and neoplastic lesions of the human cheek. CI, FH, HK, IF, LI, N/C, PP
77  1997 Changes in p53 and Waf1p21 expression and cell proliferation in esophageal carcinogenesis. ABC, BCH, PCNA, SCC
78  1997 Clinical and experimental study on therapeutic effect of Weixibaonizhuanwan on gastric precancerous lesions. CEA, IM, PCNA
79  1997 Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area. ABC, AC, BCH, BrdU, PCNA, SCC
80  1997 [Analysis of apoptosis in premalignant and malignant epithelia of buccal mucosa]. IF, SCC
81  1995 A quantitative investigation of immunocytochemically stained blood vessels in normal, benign, premalignant and malignant human oral cheek epithelium. CI, EAC, FH, LIP, mAb, SCC
82  1995 [Multiple gene alterations involved in the processor of human gastric carcinogenesis]. HGC
83  1994 Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. AC, BCH, CAG, CSG, PCNA, SCC
84  1992 Comparison of the anatomic distribution of stomach cancer and precancerous gastric lesions. CAG, IM, SC